Market Access/ News/ News/ News/ Patients

FDA starts review of first drug for alpha-mannosidosis, from Chiesi

, , , , 0 Comment

The FDA has started a priority review of Chiesi ‘s velmanase alfa, an enzyme replacement therapy for lysosomal